CoChat

Exposure to bacterial endotoxin generates a distinct strain of α-synuclein fibril

Open access

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

A single amyloidogenic protein is implicated in multiple neurological diseases and capable of generating a number of aggregate “strains” with distinct structures. Among the amyloidogenic proteins, α-synuclein generates multiple patterns of proteinopathies in a group of diseases, such as Parkinson disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). However, the link between specific conformations and distinct pathologies, the key concept of the strain hypothesis, remains elusive. Here we show that in the presence of bacterial endotoxin, lipopolysaccharide (LPS), α-synuclein generated a self-renewable, structurally distinct fibril strain that consistently induced specific patterns of synucleinopathies in mice. These results suggest that amyloid fibrils with self-renewable structures cause distinct types of proteinopathies despite the identical primary structure and that exposure to exogenous pathogens may contribute to the diversity of synucleinopathies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep30891

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Generation of two distinct α-synuclein fibril polymorphs. (a) Experimental scheme. Endotoxin-free recombinant human α-synuclein was incubated in the presence or absence of LPS (100 μg/ml) for 10 days, and analyzed by indicated analysis. Data are representative of three independent experiments. (b,c) ThT fluorescence analysis (b) and monomer consumptions analysis (c) were performed with daily samples.
Figure 1 Generation of two distinct α-synuclein fibril polymorphs. (a) Experimental scheme. Endotoxin-free recombinant human α-synuclein was incubated in the presence or absence of LPS (100 μg/ml) for 10 days, and analyzed by indicated analysis. Data are representative of three independent experiments. (b,c) ThT fluorescence analysis (b) and monomer consumptions analysis (c) were performed with daily samples.CC BY · PubMed Central
Figure 2 Structural analysis of two distinct α-synuclein fibril polymorphs. Endotoxin-free recombinant human α-synuclein was incubated in the presence or absence of LPS for 10 days. (a) Daily JC-1 fluorescence analysis of LPS(−) and LPS(+)α-synuclein. α-synuclein fibril, made of recombinant α-synuclein without endotoxin-removal and endotoxin-free α-synuclein monomer were used as controls. (b) Circular dichroic spectra of 9-day old LPS(−) and LPS(+)fibrils. The spectra of monomeric α-synuclein indicates a highly random coil enriched conformation, and the spectrum of LPS(+)fibril indicates a highly β-sheet enriched conformation. The spectra of LPS(−)fibril displayed an intermediate spectrum, indicating less β-sheet and more random coil than in the LPS(+)fibril. (c) Electron microscopy analysis of 9-day LPS(−) and LPS(+)fibrils. Scale bar, 200 nm.
Figure 2 Structural analysis of two distinct α-synuclein fibril polymorphs. Endotoxin-free recombinant human α-synuclein was incubated in the presence or absence of LPS for 10 days. (a) Daily JC-1 fluorescence analysis of LPS(−) and LPS(+)α-synuclein. α-synuclein fibril, made of recombinant α-synuclein without endotoxin-removal and endotoxin-free α-synuclein monomer were used as controls. (b) Circular dichroic spectra of 9-day old LPS(−) and LPS(+)fibrils. The spectra of monomeric α-synuclein indicates a highly random coil enriched conformation, and the spectrum of LPS(+)fibril indicates a highly β-sheet enriched conformation. The spectra of LPS(−)fibril displayed an intermediate spectrum, indicating less β-sheet and more random coil than in the LPS(+)fibril. (c) Electron microscopy analysis of 9-day LPS(−) and LPS(+)fibrils. Scale bar, 200 nm.CC BY · PubMed Central
Figure 3 Self-propagation of two distinct α-synuclein fibril polymorphs. (a) Preparation of LPS(−) and LPS(+)fibril seeds. Endotoxin-free α-synuclein was incubated in the absence or presence of LPS (100 μg/ml). After a 7-day incubation, each fibril (pellet) was isolated by centrifugation. Soluble α-synuclein monomer and unbound LPS were discarded using wash/centrifugation method. Fibrils were briefly sonicated before use. (b) Scheme of seeding experiment. Endotoxin-free recombinant α-synuclein was incubated with LPS(−)fibril seeds (5%) or LPS(+)fibril seeds (5%) in the presence or absence of LPS for 1 week. Data are representative of three independent experiments. (c) Electron microscopy was performed with 6-day samples. Scale bar, 200 nm. (d,e) ThT fluorescence analysis (d) and monomer consumption (e) were performed with daily samples.
Figure 3 Self-propagation of two distinct α-synuclein fibril polymorphs. (a) Preparation of LPS(−) and LPS(+)fibril seeds. Endotoxin-free α-synuclein was incubated in the absence or presence of LPS (100 μg/ml). After a 7-day incubation, each fibril (pellet) was isolated by centrifugation. Soluble α-synuclein monomer and unbound LPS were discarded using wash/centrifugation method. Fibrils were briefly sonicated before use. (b) Scheme of seeding experiment. Endotoxin-free recombinant α-synuclein was incubated with LPS(−)fibril seeds (5%) or LPS(+)fibril seeds (5%) in the presence or absence of LPS for 1 week. Data are representative of three independent experiments. (c) Electron microscopy was performed with 6-day samples. Scale bar, 200 nm. (d,e) ThT fluorescence analysis (d) and monomer consumption (e) were performed with daily samples.CC BY · PubMed Central
Figure 4 Comparison of 2D 20 ms mixing time DARR spectra of uniformly 13C/15N-labeled α-synuclein fibrils generated by seeding with two types of fibrils. The two types of fibrils, LPS(−)fibril (blue) and LPS(+)fibril (red) were obtained under identical fibrillation conditions. Significant differences are observed throughout the spectra, and are especially clear in the serine region (cross peaks between ~54–59 PPM and ~64–69 PPM, marked by the hashed box). The left panel displays cross peaks between the aliphatic and carbonyl regions, while the right panel displays cross peaks within the aliphatic region.
Figure 4 Comparison of 2D 20 ms mixing time DARR spectra of uniformly 13C/15N-labeled α-synuclein fibrils generated by seeding with two types of fibrils. The two types of fibrils, LPS(−)fibril (blue) and LPS(+)fibril (red) were obtained under identical fibrillation conditions. Significant differences are observed throughout the spectra, and are especially clear in the serine region (cross peaks between ~54–59 PPM and ~64–69 PPM, marked by the hashed box). The left panel displays cross peaks between the aliphatic and carbonyl regions, while the right panel displays cross peaks within the aliphatic region.CC BY · PubMed Central
Figure 5 Uptake and degradation kinetics of two different α-synuclein strains by neuronal and microglial cells. (a,b) dSY5Y (a) and BV2 microglial (b) cells were treated with LPS(−) and LPS(+)fibrils for indicated hours. The internalized α-synuclein was determined by western blot analysis (n = 3). (c,d) Degradation of internalized α-synuclein in dSY5Y and BV2 cells were determined by western blot analysis (n = 3). dSY5Y (c) and BV2 (d) cells were treated with either LPS(−) or LPS(+)fibrils for 24 or 2 hours, respectively. After PBS wash, whole cell lysates were harvested at indicated time points, and were analyzed by western blot analysis (n = 3). Data show mean ± s.e.m., ***p < 0.001 and **p < 0.01, one-way ANOVA.
Figure 5 Uptake and degradation kinetics of two different α-synuclein strains by neuronal and microglial cells. (a,b) dSY5Y (a) and BV2 microglial (b) cells were treated with LPS(−) and LPS(+)fibrils for indicated hours. The internalized α-synuclein was determined by western blot analysis (n = 3). (c,d) Degradation of internalized α-synuclein in dSY5Y and BV2 cells were determined by western blot analysis (n = 3). dSY5Y (c) and BV2 (d) cells were treated with either LPS(−) or LPS(+)fibrils for 24 or 2 hours, respectively. After PBS wash, whole cell lysates were harvested at indicated time points, and were analyzed by western blot analysis (n = 3). Data show mean ± s.e.m., ***p < 0.001 and **p < 0.01, one-way ANOVA.CC BY · PubMed Central
Figure 6 Generation of distinct α-synucleinopathies by two different α-synuclein strains. (a,b) Wild type mice were injected with α-synuclein monomer, LPS(−)fibril seed or LPS(+)fibril seed, and distributions of phosphorylated-α-synuclein were analyzed by immunohistochemical analysis at 6 months after injection. Sections were immunolabeled with anti-phospho-α-synuclein (1175) antibody (n = 5 per each group). (a) Representative low-power (upper panels) and high-power (lower panels) images of ipsilateral striatum and auditory cortex. Arrows highlight phospho-α-synuclein-positive structures. Scale bars, 50 μm (low-power) and 25 μm (high-power). (b) Semi-quantitative grading of α-synuclein pathology in the injected mice.
Figure 6 Generation of distinct α-synucleinopathies by two different α-synuclein strains. (a,b) Wild type mice were injected with α-synuclein monomer, LPS(−)fibril seed or LPS(+)fibril seed, and distributions of phosphorylated-α-synuclein were analyzed by immunohistochemical analysis at 6 months after injection. Sections were immunolabeled with anti-phospho-α-synuclein (1175) antibody (n = 5 per each group). (a) Representative low-power (upper panels) and high-power (lower panels) images of ipsilateral striatum and auditory cortex. Arrows highlight phospho-α-synuclein-positive structures. Scale bars, 50 μm (low-power) and 25 μm (high-power). (b) Semi-quantitative grading of α-synuclein pathology in the injected mice.CC BY · PubMed Central
Figure 7 Characterization of the phosphorylated-α-synuclein structures in seeds-injected mice brain. The phosphorylated-α-synuclein structures in the striatum of seed-injected mice were analyzed by double-immunolabeling analysis. The brain sections were incubated with one of following primary antibodies combinations; p-α-Syn (1175)/p-α-Syn (clone#64), p-α-Syn (1175)/NeuN, p-α-Syn (clone#64)/ubiquitin, and p-α-Syn (clone#64)/p62SQSTM1. Scale bar, 25 μm.
Figure 7 Characterization of the phosphorylated-α-synuclein structures in seeds-injected mice brain. The phosphorylated-α-synuclein structures in the striatum of seed-injected mice were analyzed by double-immunolabeling analysis. The brain sections were incubated with one of following primary antibodies combinations; p-α-Syn (1175)/p-α-Syn (clone#64), p-α-Syn (1175)/NeuN, p-α-Syn (clone#64)/ubiquitin, and p-α-Syn (clone#64)/p62SQSTM1. Scale bar, 25 μm.CC BY · PubMed Central
Figure 8 Microglial activation in seed-injected mice brain. Microglia activation were analyzed by immunohistochemical analysis 6 months after injection. Immunoreactivity against Iba-1 was analyzed in ipsilateral striatum of the brains (n = 5 per group). (a) Representative images of ipsilateral striatum. (b,c) Optical density of Iba-1 immunoreactivity (b) and percentage of Iba-1-positive area (c). Data show mean ± s.e.m., **p < 0.01 and *p < 0.05, one-way ANOVA, scale bar, 25 μm.
Figure 8 Microglial activation in seed-injected mice brain. Microglia activation were analyzed by immunohistochemical analysis 6 months after injection. Immunoreactivity against Iba-1 was analyzed in ipsilateral striatum of the brains (n = 5 per group). (a) Representative images of ipsilateral striatum. (b,c) Optical density of Iba-1 immunoreactivity (b) and percentage of Iba-1-positive area (c). Data show mean ± s.e.m., **p < 0.01 and *p < 0.05, one-way ANOVA, scale bar, 25 μm.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Cited by

See all 138

Metadata

Authors
Kim, C., Lv, G., Lee, J. S., Jung, B. C., Masuda-Suzukake, M., Hong, C.-S., Valera, E., Lee, H.-J., Paik, S. R., Hasegawa, M., Masliah, E., Eliezer, D., & Lee, S.-J.
Affiliations
  • Seoul National University (KR)
  • Weill Cornell Medicine (US)
  • University of California San Diego (US)
  • Konkuk University (KR)
  • Tokyo Metropolitan Institute of Medical Science (JP)
Corresponding author
Lee, Seung-Jae
Venue
Scientific Reports
Published
2016-08-04
Volume
6
Issue
1
Pages
30891-30891
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2486618134
Cited by
138
References
44
Citations by year
2026: 3 · 2025: 12 · 2024: 6 · 2023: 14 · 2022: 22 · 2021: 29 · 2020: 16 · 2019: 15 · 2018: 15 · 2017: 6
FWCI
9.02
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • Seoul National University Open Repository (Seoul National University) (submittedVersion)
Funders
  • National Research Foundation
  • Fonds National de la Recherche Luxembourg
  • National Institute on Aging (R37AG018440, R01AG018440, P50AG005131, R37AG019391, R01AG043384)
  • National Institute of Neurological Disorders and Stroke (P30NS057096)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
alpha-synuclein, lipopolysaccharide, bacterial endotoxin, synucleinopathies, Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, protein aggregation, amyloid conformation, neurodegeneration
MeSH terms
Amyloid, Animals, Cells, Cultured, Female, Humans, Lipopolysaccharides, Mice, Inbred C57BL, Neurons, Parkinson Disease, Protein Structure, Tertiary, Microglia, Multiple System Atrophy, Lewy Body Disease, Protein Transport, Mice, alpha-Synuclein, Protein Aggregates

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.